BiotechTube
P1vital

P1vital

Oxford, United Kingdom· Est.
p1vital.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4.3M

Overview

P1vital operates at the intersection of neuroscience research and digital health, providing technology-enabled solutions for CNS clinical trials. Its core offerings include a configurable eCOA platform for patient-reported outcomes and a library of pre-validated digital cognitive and behavioral tasks used as objective biomarkers. The company leverages over 20 years of scientific expertise to help pharmaceutical sponsors optimize trial design, enrich study populations, and make more informed drug development decisions, particularly in psychiatry and neurology.

NeurosciencePsychiatryNeurology

Technology Platform

A dual-platform approach combining: 1) A configurable, secure eCOA (electronic Clinical Outcome Assessment) software for digitizing patient-reported outcomes, and 2) A library of pre-validated digital cognitive and behavioral biomarker tasks (e.g., Facial Expression Recognition Task) grounded in neuropsychology, used to objectively assess CNS function in clinical trials.

Funding History

2
Total raised:$4.3M
Grant$1.8M
Grant$2.5M

Opportunities

The growing regulatory and industry push for objective digital endpoints in CNS trials creates a significant expansion opportunity for P1vital's validated tools.
The company is well-positioned to capitalize on the trend towards precision psychiatry and neurology, using its biomarkers for patient stratification and as sensitive measures of treatment response in early-phase trials.

Risk Factors

Key risks include slower-than-expected adoption of novel digital biomarkers by pharmaceutical sponsors for pivotal trials, and intense competition from larger eCOA vendors and other digital health startups.
The business also faces validation risk, as the long-term utility of its tools depends on continued scientific and regulatory qualification.

Competitive Landscape

P1vital competes in the eCOA space with large, established clinical trial technology providers like Medidata (a Dassault Systèmes company) and IQVIA, and in the digital biomarker space with neuroscience-focused firms such as Cogstate, Cambridge Cognition, and Biohaven. Its differentiation lies in its deep, founder-led neuroscience expertise and its specific focus on validated emotional and cognitive processing tasks for psychiatry.

More companies in United Kingdom →